GYNECOLOGIC ONCOLOGY, cilt.97, sa.1, ss.74-79, 2005 (SCI-Expanded)
Objective. The aim of this study was to assess the survival benefit of salvage surgical cytoreduction in patients with recurrent ovarian cancer and compare the surgical outcorne with salvage chemotherapy alone.